China SXT Pharmaceuticals, Inc. SXTC Open China SXT Pharmaceuticals, Inc. in new tab
China SXT Pharmaceuticals, Inc. Analysis (SXTC)
Is China SXT Pharmaceuticals, Inc. a good investment? China SXT Pharmaceuticals, Inc. (SXTC) is currently trading at 1.57 USD.
In terms of valuation, the stock trades at a P/E ratio of 0.01. This relatively low multiple may signal that China SXT Pharmaceuticals, Inc. is undervalued compared to historical market norms.
Investor FAQ
Does China SXT Pharmaceuticals, Inc. pay a dividend?
No, it does not currently pay a dividend.
What asset class is China SXT Pharmaceuticals, Inc.?
China SXT Pharmaceuticals, Inc. is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.
Company Profile
China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, ShaRen, and ChenXiang. It provides its products under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. The company serves pharmaceutical companies, chain pharmacies, and hospitals, as well as pharmaceutical distributors. China SXT Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in Taizhou, China.
Dividends
Historical Split Corporate Actions
| Split Date | Split Ratio to 1 |
|---|---|
| Feb. 22, 2021 | 0.250000 |
| Oct. 5, 2023 | 0.040000 |
| Feb. 3, 2026 | 0.010000 |
| Feb. 25, 2025 | 0.120000 |
| May 19, 2022 | 0.050000 |
Explore Premium Features
Unlock detailed news and exclusive insights with our Premium subscription.
See Pricing Plans
Community Discussion